The U.S. Food and Drug Administration (FDA) has approved Inluriyo (imlunestrant) for the treatment of adults with estrogen ...
The FDA has granted breakthrough therapy designation to ficerafusp alfa with Keytruda for some patients with head and neck squamous cell carcinoma.
Dr. Alison Ankiewicz specializes in pelvic health, helping women manage cancer-related pelvic issues through hands-on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback